These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34866200)

  • 21. Stress and Exposure Time on von Willebrand Factor Degradation.
    Jhun CS; Siedlecki C; Xu L; Lukic B; Newswanger R; Yeager E; Reibson J; Cysyk J; Weiss W; Rosenberg G
    Artif Organs; 2019 Feb; 43(2):199-206. PubMed ID: 30374981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
    Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
    Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
    Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
    Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
    Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
    Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
    Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
    Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings.
    Dassanayaka S; Slaughter MS; Bartoli CR
    ASAIO J; 2013; 59(2):123-9. PubMed ID: 23438773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices.
    Muthiah K; Connor D; Ly K; Gardiner EE; Andrews RK; Qiao J; Rutgers D; Robson D; Low J; Jarvis S; Macdonald P; Dhital K; Jansz P; Joseph J; Hayward CS
    J Heart Lung Transplant; 2016 Jun; 35(6):743-51. PubMed ID: 26987598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleeding.
    Hennessy-Strahs S; Kang J; Krause E; Dowling RD; Rame JE; Bartoli CR
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):196-204. PubMed ID: 35501195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual Variability in von Willebrand Factor Fragility in Response to Shear Stress: A Possible Clue for Predicting Bleeding Risk.
    Sakatsume K; Akiyama M; Sakota D; Hijikata W; Horiuchi H; Maruyama O; Saiki Y
    ASAIO J; 2022 Sep; 68(9):1128-1134. PubMed ID: 34967782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.
    Coghill PA; Kanchi S; Azartash-Namin ZJ; Long JW; Snyder TA
    ASAIO J; 2019 Jul; 65(5):481-488. PubMed ID: 30004942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleeding in patients with continuous-flow left ventricular assist devices: acquired von Willebrand disease or antithrombotics?
    Consolo F; Marasi A; Della Valle P; Bonora M; Pieri M; Scandroglio AM; Redaelli A; Zangrillo A; D'Angelo A; Pappalardo F
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 34718493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired von Willebrand syndrome associated with left ventricular assist device.
    Nascimbene A; Neelamegham S; Frazier OH; Moake JL; Dong JF
    Blood; 2016 Jun; 127(25):3133-41. PubMed ID: 27143258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
    Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.
    Hu J; Mondal NK; Sorensen EN; Cai L; Fang HB; Griffith BP; Wu ZJ
    J Heart Lung Transplant; 2014 Jan; 33(1):71-9. PubMed ID: 24055626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
    Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
    Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.